DNA Script has partnered with Imperial Life Sciences (ILS) to expand access to its SYNTAX platform across India, enabling researchers to produce single-stranded DNA (ssDNA) oligonucleotides directly in their laboratories. The automated benchtop system synthesizes, purifies, and normalizes DNA in just a few hours, reducing dependence on overseas suppliers and accelerating research workflows. Capable of generating up to 384 oligonucleotides in parallel, the platform supports faster design-build-test cycles for a wide range of life science applications. The collaboration aims to strengthen India’s rapidly growing biotechnology sector by providing local sales, technical support, and quicker access to advanced DNA synthesis technology.
Read more at NewsMedical